Pennsylvania MMJ Framework Remains in Limbo
September 28th, 2015
Pennsylvania’s House of Representatives spent the summer months drafting the initial framework for a medical marijuana system and plan to send the recommendations to the GOP House Majority Leader Dave Reed in the coming weeks.
With nearly 90% support among the state’s residents, the House leadership has placed a high priority on passing the bill into law. The legislators had originally hoped to pass the bill before the summer break, but as disagreements over what medical conditions should be covered, how many dispensaries should be permitted, and what state entity would oversee the rollout of the program has resulted in a refusal by the House to act.
Many advocates worry that the House may be tempted to write a brand new bill that would have to go back to the Senate before approval and could take time. On the other hand, an amendment to SB3 – the Senate’s already-approved version – could shorten the timeline with a simple yes or no vote in the House. The key will be just how different SB3 will be, which could create problems in the Senate as it’s forced to review any changes.
The good news is that Governor Tom Wolf has already come out in favor of such a bill, which means that the executive branch poses little threat to the passage of any compassionate use legislation. Once the bill passes on a government level, supports expect another two years before the program is up and running providing medical marijuana in the state – a timeline that has left many patients in need frustrated with the slow progress despite strong support.
In the end, it’s clear that Pennsylvanians are in favor of medical marijuana, but the timeline towards a legalized program remains uncertain.
Follow Us on Social Media
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating the markets, profiling public and private companies, and developing specific investor audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and publishes industry news, thought leader and executive interviews, and stories on the fluid business and regulatory environment while serving as a leading corporate communications platform for companies operating in the industry.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.